Form 8-K Embrace Change Acquisiti For: Sep 10
false
0001869601
0001869601
2026-09-10
2026-09-10
0001869601
EMCGU:UnitsEachConsistingOfOneOrdinaryShareOfParValue0.0001OneWarrantAndOneRightMember
2026-09-10
2026-09-10
0001869601
EMCGU:OrdinarySharesParValue0.0001PerShareIncludedAsPartOfUnitsMember
... (continue reading...)
Form 8-K Lipocine Inc. For: Sep 14
false
0001535955
0001535955
2026-09-14
2026-09-14
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
Form D/A Bin Yuan Greater China
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form D/A L&R ASIA CREDIT ALPHA
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 6-K NOVONIX Ltd For: Sep 14
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2026
001-41208
(Commission File Number)
NOVONIX LIMITED
(Translation of registrant’s name into English)
Level 38
71 Eagle Street
Brisbane, QLD 4000 Australia
More SEC Filings
View Older Stories-
Form 6-K Radiopharm Theranostics For: Sep 14
-
Form 425 Translational Developmen Filed by: Prologium Holding Inc.
-
Form 6-K Zhihu Inc. For: Sep 14
-
Form 6-K Clearmind Medicine Inc. For: Sep 14
-
Form F-3 Radiopharm Theranostics
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form FWP JPMORGAN CHASE & CO Filed by: JPMORGAN CHASE & CO
-
Form 6-K Li Auto Inc. For: Sep 14
-
Form D/A Sage Partners Alpha 1
-
Form SCHEDULE 13G/A Grab Holdings Ltd Filed by: TOYOTA MOTOR CORP/
-
Form 3 Polar Power, Inc. For: Aug 17 Filed by: Ahern Jim
-
Form SCHEDULE 13G Safe Pro Group Inc. Filed by: FROST PHILLIP MD ET AL
-
Form 8-K WhiteFiber, Inc. For: Sep 14
-
Form 6-K PRUDENTIAL PLC For: Sep 14
-
Form S-1/A Electra Therapeutics,
-
Form 4 Alibaba Group Holding For: Sep 10 Filed by: Wu Yongming
-
Form 1-SA McQueen Labs Series, For: Jun 30
-
Form C/A Oravanti Ventures Inc
-
Form S-3ASR Tyra Biosciences, Inc.
-
Form DEF 14C SHARING ECONOMY INTERNAT For: Sep 14
-
Form 424B2 Jefferies Financial Grou
-
Form 6-K WOODSIDE ENERGY GROUP For: Sep 14
-
Form 15-12G Apogee Therapeutics,
-
Form 8-K Artificial Intelligence For: Sep 14
-
Form EFFECT ACCURAY INC
-
Form 6-K Biophytis SA For: Sep 11
-
Form FWP ROYAL BANK OF CANADA Filed by: ROYAL BANK OF CANADA
-
Form 6-K KE Holdings Inc. For: Sep 14
-
Form 4 NEONC TECHNOLOGIES HOLDI For: Sep 11 Filed by: Heshmatpour Amir F
-
Form EFFECT Eightco Holdings Inc.
-
Form EFFECT Wheeler Real Estate Inve
-
Form 6-K Nanobiotix S.A. For: Sep 14
-
Form EFFECT Strategic Storage Trust
-
Form EFFECT VS MEDIA Holdings Ltd
-
Form EFFECT Indivior Pharmaceuticals
-
Form 8-K ORACLE CORP For: Sep 12
-
Form 6-K NOMURA HOLDINGS INC For: Sep 14
-
Form EFFECT Nasus Pharma Ltd
-
Form EFFECT ENIGMATIG LTD
-
Form EFFECT First Breach, Inc.
-
Form EFFECT Regan Capital Alternativ
-
Form SUPPL THOMSON REUTERS CORP
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B5 Thomson Reuters (Tax & Filed by: West Publishing Corp
-
Form EFFECT Can-Fite BioPharma Ltd.
-
Form 1-SA LianSheng Group Inc For: Jun 30
-
Form EFFECT Calisa Acquisition Corp
-
Form S-1/A Eaglesky Acquisition
